FDA and EMA authorize phase 3 trial of masitinib for mCRPC
Expanded indication sought for niraparib plus AAP in Europe
Regulatory recap: FDA approvals in urology from the first half of 2025
Top 10 Urology Times videos from the first half of 2025
